Yoon Aera, Choi Chel Hun, Lee Yoo-Young, Kim Tae-Joong, Lee Jeong-Won, Kim Byoung-Gie, Bae Duk-Soo
Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Int J Gynecol Cancer. 2015 Jul;25(6):1051-7. doi: 10.1097/IGC.0000000000000407.
This study aimed to compare the laparoscopic-assisted radical vaginal trachelectomy (LARVT) and laparoscopic radical trachelectomy (LRT) surgical approaches and provide outcome data on patients who have undergone radical trachelectomy.
We identified patients who had undergone LARVT or LRT at Samsung Medical Center between January 2005 and March 2013.
A total of 38 patients were identified, and 21 patients had undergone LARVT, whereas 17 patients had undergone LRT. The median age was 32 years for both groups. Most of the patients had a squamous cell carcinoma (68.4%) and International Federation of Gynecology and Obstetrics stage IB1 disease (76.3%). Twenty (52.6%) of 38 patients had tumor size greater than 2 cm. There were no significant differences between groups in the baseline characteristics except for the tumor size. Patients undergoing LRT had significantly larger tumor size than patients undergoing LARVT (median tumor size, 2.7 cm [range, 1.2-3.7] vs 2.1 cm [range, 0.4-3.0], P = 0.032). Perioperative outcomes were similar between groups except for the decline of hemoglobin after surgery. The median decline of hemoglobin indicating blood loss was significantly smaller in the LRT group than in the LARVT group (1.8 g/dL [range, 0.5-3.5] vs 2.6 g/dL [range, 0.7-6.2], P = 0.017). Intraoperative complications occurred in 2 patients (9.5%, 2/21) in LARVT group. Although 52.6% of tumors were larger than 2 cm, recurrence occurred only in 3 (7.9%) patients who underwent LARVT.
The study shows the feasibility of LRT, with the advantage of reduced blood loss. The LRT could be an alternative option for patients with large tumors. Further researches are needed to investigate the long-term outcomes.
本研究旨在比较腹腔镜辅助根治性阴道宫颈切除术(LARVT)和腹腔镜根治性宫颈切除术(LRT)的手术方法,并提供接受根治性宫颈切除术患者的预后数据。
我们确定了2005年1月至2013年3月期间在三星医疗中心接受LARVT或LRT的患者。
共确定38例患者,其中21例行LARVT,17例行LRT。两组的中位年龄均为32岁。大多数患者为鳞状细胞癌(68.4%),国际妇产科联盟分期为IB1期疾病(76.3%)。38例患者中有20例(52.6%)肿瘤大小大于2 cm。除肿瘤大小外,两组的基线特征无显著差异。接受LRT的患者肿瘤大小明显大于接受LARVT的患者(中位肿瘤大小,2.7 cm[范围,1.2 - 3.7] vs 2.1 cm[范围,0.4 - 3.0],P = 0.032)。除术后血红蛋白下降外,两组围手术期结局相似。LRT组表明失血的血红蛋白中位下降明显小于LARVT组(1.8 g/dL[范围,0.5 - 3.5] vs 2.6 g/dL[范围,0.7 - 6.2],P = 0.017)。LARVT组有2例患者发生术中并发症(9.5%,2/21)。尽管52.6%的肿瘤大于2 cm,但仅3例(7.9%)接受LARVT的患者出现复发。
该研究表明LRT具有可行性,具有减少失血的优势。LRT可能是大肿瘤患者的替代选择。需要进一步研究以调查长期结局。